Administration of follitropin alfa and lutropin alfa combined in a single injection: a feasibility assessment. - Wikidata - wikimedia - TriplyDB

Administration of follitropin alfa and lutropin alfa combined in a single injection: a feasibility assessment.

Administration of follitropin alfa and lutropin alfa combined in a single injection: a feasibility assessment.

http://www.wikidata.org/entity/Q37207662

about

Profile of follitropin alpha/lutropin alpha combination for the stimulation of follicular development in women with severe luteinizing hormone and follicle-stimulating hormone deficiency Recombinant follitropin alfa/lutropin alfa in fertility treatment.A 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice: a large, multicentre, observational study A large, multicentre, observational, post-marketing surveillance study of the 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice for assisted reproductive technology.

P2860

Q26745764-D34D51EA-C7F7-4FA9-9110-022F46B8CFDF Q33644799-6E78FAF3-D8D7-4AF7-A394-9785900B860A Q35197790-3D2C20FC-7CCB-4BD5-A8D6-BE2BEA556F85 Q37515703-94870487-3323-4D3E-886A-7A9B0E89E645

P2860

Administration of follitropin alfa and lutropin alfa combined in a single injection: a feasibility assessment.

http://www.wikidata.org/entity/Q37207662

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Administration of follitropin ...... ion: a feasibility assessment.

@en

Administration of follitropin ...... ion: a feasibility assessment.

@nl

type

label

Administration of follitropin ...... ion: a feasibility assessment.

@en

Administration of follitropin ...... ion: a feasibility assessment.

@nl

prefLabel

Administration of follitropin ...... ion: a feasibility assessment.

@en

Administration of follitropin ...... ion: a feasibility assessment.

@nl

P1433

Q37207662-26DA55B6-C544-4BA4-A037-026F446C4659

P1476

Q37207662-044F0161-E198-495E-8E3B-66AC9A5B3273

P2093

Q37207662-0CAE4B70-4AF6-4AD5-8749-797AA7F99EA1

P2860

Q37207662-01C30FBC-8191-431D-A100-CB4F749D4292

Q37207662-073B34BD-A05D-4B31-9D8E-2D85735A5178

Q37207662-136FD63D-77EB-4C95-8D04-95EE2983B212

Q37207662-5A8F4DE0-714E-4219-8152-3FDE7808BD3B

Q37207662-67129854-0893-4764-A151-F4B1C1AE5020

Q37207662-6CFFA7D2-E443-4B66-99AE-1D133B3B62B1

Q37207662-7231528B-E66E-4982-96F4-E0B33EB3527F

Q37207662-72EBFC83-02D0-464E-ACBD-DBF56979C3C4

Q37207662-927D5F70-950D-45A0-9298-9E42260111AD

Q37207662-9C829281-B43A-4458-8C77-DF126CDB9296

P2888

Q37207662-64B01291-1B8E-4E9A-A403-355A594E2588

P304

Q37207662-35B15FA8-0A58-437F-8502-B3368EC8FA25

P31

Q37207662-5FFEE953-4ED2-444D-B43F-36798F1A6804

P356

Q37207662-2CF936F6-8E22-46D0-BDF5-3E3C974EE72F

P478

Q37207662-A247A42B-74A6-4155-968D-0558E1563927

P577

Q37207662-5158CB9D-892D-4604-80EF-A06F3284B1BD

P5875

Q37207662-B5798646-47DB-4127-8C02-8951EB41E345

P6179

Q37207662-4D693BC8-0D11-491B-979D-8D3FB9004816

P698

Q37207662-62535D4B-40F5-4557-A06D-C25CB0C530A8

P932

Q37207662-89240A0E-18D6-46E2-9AFE-D58BC65681CE

P356

P1433

Reproductive Biology and Endocrinology

P1476

Administration of follitropin ...... ion: a feasibility assessment.

@en

P2093

Rita Agostinetto

http://www.w3.org/2001/XMLSchema#string

P2860

Mixed protocols: multiple ratios of FSH and LH bioactivity using highly purified, human-derived FSH (BRAVELLE) and highly purified hMG (MENOPUR) are unaltered by mixing together in the same syringe.

Historical perspectives in gonadotrophin therapy.

Assessment of the biopotency of follitropin alfa and lutropin alfa combined in one injection: a comparative trial in Sprague-Dawley rats

Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis.

Clinical pharmacology of recombinant human follicle-stimulating hormone. III. Pharmacokinetic-pharmacodynamic modeling after repeated subcutaneous administration.

The fourth International Standard for Human Urinary FSH and LH: specificities of LH seminal vesicle weight gain assays in the collaborative study differ between laboratories.

Quantification of follicle stimulating hormone (follitropin alfa): is in vivo bioassay still relevant in the recombinant age?

Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment.

Patient and nurse evaluation of recombinant human follicle-stimulating hormone administration methods: comparison of two follitropin injection pens.

Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone.

P2888

P304

48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1477-7827-7-48

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24435115

http://www.w3.org/2001/XMLSchema#string

P6179

1052960358

http://www.w3.org/2001/XMLSchema#string

P698

19450267

http://www.w3.org/2001/XMLSchema#string

P932

2688505

http://www.w3.org/2001/XMLSchema#string